Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > R&F product launch.... or is it a failure to launch?
View:
Post by Pareto8020 on Aug 06, 2020 2:07pm

R&F product launch.... or is it a failure to launch?

I wonder what R&F's idea of "up and coming" converts to in years or months?  Here we are 11 months since this deal was announced and zippo TFC-1067 in any retail product yet.  If it isn't included in the next launch this deal is about as good as SBM's current shareprice which is now equivalent to what it was trading at in 2016. 

The share price clearly shows that SBM hasn't had the right PR company (or management in some cases) on board since a reputable company would have built up their share price as SBM built up their pipeline and moved compounds to market ready status.  There is no momentum behind SBM and ironically they are using Momentum PR to try and do just that.  Only thing that will be moving SBM shareprice now are revenue$$$.     


“As a company committed to innovation, Rodan + Fields continually seeks out novel and groundbreaking technologies. We’re excited to partner with Sirona to commercialize this highly novel new molecule in an up-and-coming product release and deliver the well-validated benefits to our consumer base”, said Dr. Simon Craw, Senior Director of R&D Read more here...

https://www.sironabiochem.com/sirona-biochem-signs-definitive-license-supply-agreement-with-skincare-industry-leader-rodan-fields/
Comment by JohnFriesen on Aug 06, 2020 3:05pm
This post has been removed in accordance with Community Policy
Sirona Biochem Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities